Abbott Laboratories (ABT) News Today $134.92 +1.75 (+1.32%) As of 11:01 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Abbott Declares 405th Consecutive Quarterly DividendFebruary 21 at 10:48 AM | prnewswire.comBradley Foster & Sargent Inc. CT Grows Stock Holdings in Abbott Laboratories (NYSE:ABT)Bradley Foster & Sargent Inc. CT grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 5.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 635,753 shares of the healthcare product maker's stoFebruary 21 at 7:07 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Paradigm Asset Management Co. LLCParadigm Asset Management Co. LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 21.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,000 shares of the healthcare product maker's stock afterFebruary 21 at 6:54 AM | marketbeat.comCordatus Wealth Management LLC Acquires Shares of 23,574 Abbott Laboratories (NYSE:ABT)Cordatus Wealth Management LLC bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 23,574 shares of the healthcare product maker's stocFebruary 21 at 6:32 AM | marketbeat.comNicholson Wealth Management Group LLC Raises Stake in Abbott Laboratories (NYSE:ABT)Nicholson Wealth Management Group LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 90.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,591 shares of the healthcaFebruary 21 at 5:53 AM | marketbeat.comAdvyzon Investment Management LLC Acquires New Holdings in Abbott Laboratories (NYSE:ABT)Advyzon Investment Management LLC bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,963 shares of the healthcare product mFebruary 21 at 4:54 AM | marketbeat.comMeitav Investment House Ltd. Reduces Stake in Abbott Laboratories (NYSE:ABT)Meitav Investment House Ltd. lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 75.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,500 shares of the healthcare product makerFebruary 21 at 4:54 AM | marketbeat.comStrategic Financial Concepts LLC Takes $316,000 Position in Abbott Laboratories (NYSE:ABT)Strategic Financial Concepts LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 2,792 shares of the healthcare product maker's stock, valued at apFebruary 21 at 3:40 AM | marketbeat.comGov. Greg Abbott awards Austin-based Silicon Labs $23.25M in Texas CHIPS Act fundingFebruary 21 at 12:53 AM | msn.comAbbott Laboratories (NYSE:ABT) Reaches New 52-Week High - Here's WhyAbbott Laboratories (NYSE:ABT) Sets New 52-Week High - Here's What HappenedFebruary 20 at 12:32 PM | marketbeat.comING Groep NV Sells 99,117 Shares of Abbott Laboratories (NYSE:ABT)ING Groep NV lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 353,673 shares of the healthcare product maker's stock afFebruary 20 at 7:11 AM | marketbeat.comParcion Private Wealth LLC Buys 2,161 Shares of Abbott Laboratories (NYSE:ABT)Parcion Private Wealth LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 3.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 68,187 shares of the healthcare product maker's stock after purchasing an additionFebruary 20 at 7:10 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Holdings Decreased by Flossbach Von Storch SEFlossbach Von Storch SE reduced its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,672,425 shares of the healthcare product mFebruary 20 at 7:08 AM | marketbeat.comBoston Financial Mangement LLC Decreases Position in Abbott Laboratories (NYSE:ABT)Boston Financial Mangement LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,177 shares of the healthcare product maker'sFebruary 20 at 6:36 AM | marketbeat.comHandelsbanken Fonder AB Reduces Holdings in Abbott Laboratories (NYSE:ABT)Handelsbanken Fonder AB cut its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 20.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,344,134 shares of the healthcare product maker's stock aftFebruary 20 at 6:07 AM | marketbeat.comCorps Capital Advisors LLC Takes Position in Abbott Laboratories (NYSE:ABT)Corps Capital Advisors LLC acquired a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,201 shares of the healthcare pFebruary 20 at 5:42 AM | marketbeat.comIeq Capital LLC Raises Stake in Abbott Laboratories (NYSE:ABT)Ieq Capital LLC boosted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 21.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 135,060 shares of the healthcare product maker's stock afterFebruary 20 at 5:34 AM | marketbeat.comPrivate Advisor Group LLC Acquires 90,662 Shares of Abbott Laboratories (NYSE:ABT)Private Advisor Group LLC grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 56.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,083 shares of the healthcare productFebruary 19 at 7:41 AM | marketbeat.comAlberta Investment Management Corp Grows Holdings in Abbott Laboratories (NYSE:ABT)Alberta Investment Management Corp lifted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 135.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 139,635 shares of the healthcaFebruary 19 at 7:24 AM | marketbeat.comGlobal Retirement Partners LLC Has $6.63 Million Stake in Abbott Laboratories (NYSE:ABT)Global Retirement Partners LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 58,604 shares of the healthcare product maker's stock after acFebruary 19 at 6:28 AM | marketbeat.comDSM Capital Partners LLC Acquires 370,049 Shares of Abbott Laboratories (NYSE:ABT)DSM Capital Partners LLC lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 75.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 859,404 shares of the healthcare product maker's stock after purchasing anFebruary 19 at 6:28 AM | marketbeat.comAtlas Legacy Advisors LLC Acquires New Shares in Abbott Laboratories (NYSE:ABT)Atlas Legacy Advisors LLC bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,883 shares of the healthcare pFebruary 19 at 5:57 AM | marketbeat.comBank of Jackson Hole Trust Purchases New Position in Abbott Laboratories (NYSE:ABT)Bank of Jackson Hole Trust purchased a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,039 shares of the healthcare product maker's stock, valued at approximately $344,000. OthFebruary 19 at 5:48 AM | marketbeat.comNew York State Common Retirement Fund Has $263.92 Million Holdings in Abbott Laboratories (NYSE:ABT)New York State Common Retirement Fund lowered its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 0.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,333,306 shares of the healthcare product maker'February 19 at 5:40 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Holdings Boosted by Atria Wealth Solutions Inc.Atria Wealth Solutions Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 77,402 shares of the healthcare product maker's stock afterFebruary 19 at 5:14 AM | marketbeat.com10,812 Shares in Abbott Laboratories (NYSE:ABT) Purchased by GAM Holding AGGAM Holding AG bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,812 shares of the healthcare product maker's stock, valued at approximately $1,22February 19 at 5:07 AM | marketbeat.comCallahan Advisors LLC Buys 10,022 Shares of Abbott Laboratories (NYSE:ABT)Callahan Advisors LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 84,439 shares of the healthcare product maker's stock after acquiring an additional 10,022 sFebruary 18 at 7:32 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by Kentucky Retirement Systems Insurance Trust FundKentucky Retirement Systems Insurance Trust Fund raised its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 6.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owFebruary 18 at 7:10 AM | marketbeat.comRamsay Stattman Vela & Price Inc. Increases Stock Holdings in Abbott Laboratories (NYSE:ABT)Ramsay Stattman Vela & Price Inc. increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 6.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 111,095 shares of the healthcare product maker's stock after acquiringFebruary 18 at 7:08 AM | marketbeat.comBuckingham Capital Management Inc. Sells 24,982 Shares of Abbott Laboratories (NYSE:ABT)Buckingham Capital Management Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 55.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 20,427 shares of the healthcare product maker's stock afteFebruary 18 at 6:31 AM | marketbeat.comKornitzer Capital Management Inc. KS Boosts Stock Position in Abbott Laboratories (NYSE:ABT)Kornitzer Capital Management Inc. KS boosted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 392,611 sharFebruary 18 at 5:51 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Stock Holdings Lifted by Venturi Wealth Management LLCVenturi Wealth Management LLC grew its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,292 shares of the healthcare product maker'sFebruary 18 at 5:44 AM | marketbeat.comD.A. Davidson & CO. Buys 2,493 Shares of Abbott Laboratories (NYSE:ABT)D.A. Davidson & CO. raised its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 157,750 shares of the healthcare product maker's stock after purchasing an additional 2,493 shares duringFebruary 18 at 5:34 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Americana Partners LLCAmericana Partners LLC lowered its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 14.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,655 shares of the healthcare product maker's stocFebruary 18 at 4:50 AM | marketbeat.comEmpower Advisory Group LLC Increases Stock Holdings in Abbott Laboratories (NYSE:ABT)Empower Advisory Group LLC lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 917,214 shares of the healthcare product maker's stock after buying an adFebruary 17, 2025 | marketbeat.comTruist Financial Corp Sells 61,579 Shares of Abbott Laboratories (NYSE:ABT)Truist Financial Corp decreased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,413,727 shares of the healthcare product maker's stock after selling 61,579February 17, 2025 | marketbeat.comCIBC Asset Management Inc Cuts Stake in Abbott Laboratories (NYSE:ABT)CIBC Asset Management Inc reduced its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 15.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 591,636 shares of the healthcarFebruary 17, 2025 | marketbeat.com9,333 Shares in Abbott Laboratories (NYSE:ABT) Acquired by AlphaCentric Advisors LLCAlphaCentric Advisors LLC acquired a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 9,333 shares of the healthcare product maker's stock,February 17, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,294,472 shares of the healthcare product maker's stock after selling 53,144 shares during theFebruary 17, 2025 | marketbeat.comSheaff Brock Investment Advisors LLC Increases Holdings in Abbott Laboratories (NYSE:ABT)Sheaff Brock Investment Advisors LLC raised its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 68.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,866 shares of theFebruary 17, 2025 | marketbeat.comPrincipal Securities Inc. Raises Stock Holdings in Abbott Laboratories (NYSE:ABT)Principal Securities Inc. increased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 25.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,759 shares of the healthcare product maker'sFebruary 17, 2025 | marketbeat.comAbbott Laboratories (ABT): Among the Best Drug Stocks to Buy NowFebruary 17, 2025 | insidermonkey.comMOKAN Wealth Management Inc. Buys Shares of 20,859 Abbott Laboratories (NYSE:ABT)MOKAN Wealth Management Inc. bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,859 shares of the healthcare product maker's stock,February 16, 2025 | marketbeat.comAllworth Financial LP Lowers Holdings in Abbott Laboratories (NYSE:ABT)Allworth Financial LP cut its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 5.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 248,817 shares of the healthcare product maker's stock after selling 13,766 shares duringFebruary 16, 2025 | marketbeat.combLong Financial LLC Takes Position in Abbott Laboratories (NYSE:ABT)bLong Financial LLC purchased a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,107 shares of the healthcare product maker's stock, valuedFebruary 16, 2025 | marketbeat.comPuff Wealth Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT)Puff Wealth Management LLC purchased a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 5,210 shares of the healthcare product maker's stock, valued at approximately $589,000. SeveralFebruary 16, 2025 | marketbeat.comMontag A & Associates Inc. Sells 1,944 Shares of Abbott Laboratories (NYSE:ABT)Montag A & Associates Inc. lowered its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 102,643 shares of the healthcare product maker's stock after selling 1,944 shares during the perFebruary 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Hits New 12-Month High - Here's What HappenedAbbott Laboratories (NYSE:ABT) Hits New 12-Month High - Should You Buy?February 15, 2025 | marketbeat.comNew York State Teachers Retirement System Sells 73,492 Shares of Abbott Laboratories (NYSE:ABT)New York State Teachers Retirement System decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,562,029 shares of the healthcare product maker's stock after selling 73,February 15, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Position Increased by Klingenstein Fields & Co. LPKlingenstein Fields & Co. LP grew its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 130,102 shares of the healthcare product maker's stock after acquiring an addFebruary 15, 2025 | marketbeat.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.560.60▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼6724▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News BSX News SYK News MDT News BDX News EW News IDXX News DXCM News RMD News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.